Cravath, Swaine & Moore LLP

New York, NY Professional servicesNAICS 541110

Self-funded health planPlan year 2025Renews January
1,483Participants+2% vs. prior year
$3.5MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#25 of 70Professional services in NYBy participants

Overview

Cravath, Swaine & Moore LLP sponsors a self-funded health plan that covered 1,483 participants in plan year 2025, up 2% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, long-term disability.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
1,483 · prior year 1,454
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Cravath, Swaine & Moore LLP Group Insurance Plan, plan 510 (1,483 participants)
Stop-loss carrier
Cigna Health & Life Insurance Company
Broker compensation
$323K across insured contracts
MedicalLife insuranceDentalVisionLong-term disabilityOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Cigna Health & Life Insurance CompanyStop-loss, Medical, Dental2,198$2.4M—
Metropolitan Life Insurance CompanyDental, Life, Medical1,450$2.3M$117K
First Unum Life Insurance CompanyLong-term disability1,060$1.1M$83K
Equitable Financial Life Insurance CompanyLife1,314$383K$42K
Sun Life and Health Insurance Company (u.s.)Life, Long-term disability86$373K$36K
Chubb - Federal Insurance CompanyBusiness Travel Accident1,182$208K$44K
Combined Insurance Company of New YorkVision1,334$113K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$3.5M/ year

Estimated prescription spend: 1,483 participants × $2,371 national average per member. Usually higher once dependents are counted.

$91K–$225K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$27K–$67K
Lower-cost therapeutic alternatives$39K–$82K
Generic pricing vs. actual cost$17K–$51K
PBM contract terms$9K–$26K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Cravath, Swaine & Moore LLP
Sponsor EIN
13-5015405
Plan number
510
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 13-5015405 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Savings Plan of Cravath, Swaine & Moore LLP
Type
401(k) plan
Participants
1,212

About this data

Source: Cravath, Swaine & Moore LLP's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Cravath, Swaine & Moore LLP.

Request a correction · Methodology